Contact
Please use this form to send email to PR contact of this press release:
Immutep Completes Recruitment of Head and Neck Cancer Patients of Phase II TACTI-002 Study
TO:
Please use this form to send email to PR contact of this press release:
Immutep Completes Recruitment of Head and Neck Cancer Patients of Phase II TACTI-002 Study
TO: